114 results
Page 4 of 6
8-K
EX-99.1
ug52ov00lm11c fzs5t
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.2
e9eoqua4lfiaaa
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.2
dce27f 2q
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
6i0xf3bhouys9d87jlby
28 Jun 21
Other Events
7:30am
8-K
EX-99.1
jle w1za3l7y2j
6 May 21
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results
4:01pm
8-K
EX-1.1
d3jixq5ehqh9kn
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
424B5
wf75vke
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
ynsnmn8fy cyzijq
30 Mar 21
Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
5:05pm
8-K
6tiaaq6q1
4 Feb 21
Other Events
7:00am
8-K
v5h37no4fz1 59cmqb
3 Feb 21
Other Events
7:00am
8-K
EX-99.1
t2wbigj07s7xdn6t
6 Nov 20
Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results
8:30am
8-K
EX-99.1
qi33gkmaawydnkdehw9
26 Oct 20
Regulation FD Disclosure
6:55am
8-K
idjr3 1xrmzxqtwt72oz
26 Oct 20
Regulation FD Disclosure
6:55am
8-K
EX-99.1
pke wx6ke8
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am